Ensysce Biosciences, Inc. (ENSC)

Last Closing Price: 2.22 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Ensysce Biosciences, Inc. (ENSC) had Net Income of $-7.99M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$5.21M
Net Income
$-7.99M
--
$5.21M
$11.94M
$-6.73M
$-1.26M
$-7.99M
$-7.99M
$-7.99M
$-7.99M
$-7.99M
$-7.99M
$-6.73M
$-5.53M
0.70M
0.70M
$-11.45
$-11.45
Balance Sheet Financials
$5.34M
--
$0.25M
$5.60M
$2.21M
--
$0.01M
$2.22M
$3.38M
$3.38M
$3.38M
1.36M
Cash Flow Statement Financials
$-7.50M
--
$9.88M
$1.12M
$3.50M
$2.38M
$0.11M
--
--
Fundamental Metrics & Ratios
2.42
--
--
--
0.09
100.00%
-129.18%
-129.18%
-106.20%
-153.30%
-153.30%
$-7.50M
--
--
--
0.93
--
41.98
8.70
-236.31%
-236.31%
-142.70%
-236.31%
$2.49
$-10.75
$-10.75